Goby Global
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline 2024-04-08 15:00
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member 2024-03-14 22:30
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications 2023-11-06 20:00
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech 2023-07-20 09:01
Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China 2023-05-08 19:30
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
Impact Therapeutics Announces Completion of Series D1 Financing 2022-03-14 12:43
1